These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24292634)

  • 21. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice.
    Kyaw T; Winship A; Tay C; Kanellakis P; Hosseini H; Cao A; Li P; Tipping P; Bobik A; Toh BH
    Circulation; 2013 Mar; 127(9):1028-39. PubMed ID: 23395974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaques.
    Quesada IM; Lucero A; Amaya C; Meijles DN; Cifuentes ME; Pagano PJ; Castro C
    Atherosclerosis; 2015 Oct; 242(2):469-75. PubMed ID: 26298737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased amount of bone marrow-derived smooth muscle-like cells and accelerated atherosclerosis in diabetic apoE-deficient mice.
    Fledderus JO; van Oostrom O; de Kleijn DP; den Ouden K; Penders AF; Gremmels H; de Bree P; Verhaar MC
    Atherosclerosis; 2013 Feb; 226(2):341-7. PubMed ID: 23219222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.
    Gray SP; Di Marco E; Okabe J; Szyndralewiez C; Heitz F; Montezano AC; de Haan JB; Koulis C; El-Osta A; Andrews KL; Chin-Dusting JP; Touyz RM; Wingler K; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Circulation; 2013 May; 127(18):1888-902. PubMed ID: 23564668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice.
    Lu Y; Qin W; Shen T; Dou L; Man Y; Wang S; Xiao C; Li J
    J Atheroscler Thromb; 2011; 18(11):998-1008. PubMed ID: 21873804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/- mice with or without diabetes.
    Hanssen NM; Brouwers O; Gijbels MJ; Wouters K; Wijnands E; Cleutjens JP; De Mey JG; Miyata T; Biessen EA; Stehouwer CD; Schalkwijk CG
    Cardiovasc Res; 2014 Oct; 104(1):160-70. PubMed ID: 25139743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice.
    Ganbaatar B; Fukuda D; Shinohara M; Yagi S; Kusunose K; Yamada H; Soeki T; Hirata KI; Sata M
    Eur J Pharmacol; 2020 May; 875():173040. PubMed ID: 32114052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
    Soro-Paavonen A; Watson AM; Li J; Paavonen K; Koitka A; Calkin AC; Barit D; Coughlan MT; Drew BG; Lancaster GI; Thomas M; Forbes JM; Nawroth PP; Bierhaus A; Cooper ME; Jandeleit-Dahm KA
    Diabetes; 2008 Sep; 57(9):2461-9. PubMed ID: 18511846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions.
    Craige SM; Kant S; Reif M; Chen K; Pei Y; Angoff R; Sugamura K; Fitzgibbons T; Keaney JF
    Free Radic Biol Med; 2015 Dec; 89():1-7. PubMed ID: 26169727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PKCε mediates resistin-induced NADPH oxidase activation and inflammation leading to smooth muscle cell dysfunction and intimal hyperplasia.
    Raghuraman G; Zuniga MC; Yuan H; Zhou W
    Atherosclerosis; 2016 Oct; 253():29-37. PubMed ID: 27573736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice.
    Buday A; Orsy P; Godó M; Mózes M; Kökény G; Lacza Z; Koller A; Ungvári Z; Gross ML; Benyó Z; Hamar P
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H386-95. PubMed ID: 20511416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators.
    Bruen R; Curley S; Kajani S; Lynch G; O'Reilly ME; Dillon ET; Brennan EP; Barry M; Sheehan S; McGillicuddy FC; Belton O
    J Pharmacol Exp Ther; 2019 Sep; 370(3):447-458. PubMed ID: 31270216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats.
    Deng W; Duan M; Qian B; Zhu Y; Lin J; Zheng L; Zhang C; Qi X; Luo M
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):255-265. PubMed ID: 30413372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice.
    Nogi Y; Nagashima M; Terasaki M; Nohtomi K; Watanabe T; Hirano T
    PLoS One; 2012; 7(4):e35683. PubMed ID: 22536426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence.
    Zhu H; Wang Z; Dong Z; Wang C; Cao Q; Fan F; Zhao J; Liu X; Yuan M; Sun X; Peng X; Zou Y; Zhou J; Ge J; Zhou X; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1782-1792. PubMed ID: 30315930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
    Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
    Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules.
    Tikellis C; Jandeleit-Dahm KA; Sheehy K; Murphy A; Chin-Dusting J; Kling D; Sebokova E; Cooper ME; Mizrahi J; Woollard KJ
    Atherosclerosis; 2008 Jul; 199(1):55-64. PubMed ID: 18093596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.